Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Infigratinib |
Trade Name | Truseltiq |
Synonyms | BGJ398|BGJ-398|BGJ 398 |
Drug Descriptions |
Truseltiq (infigratinib) is a pan-FGFR inhibitor, which inhibits tumor angiogenesis and tumor cell proliferation (PMID: 31109923, PMID: 30101387). Truseltiq (infigratinib) is FDA approved for use in patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusion or rearrangement (FDA.gov). |
DrugClasses | FGFR Inhibitor (Pan) 26 |
CAS Registry Number | 872511-34-7 |
NCIT ID | C88302 |